Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.
The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.
Health Catalyst has recently gained recognition with several achievements:
- VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
- MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
- Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
- Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.
Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.
Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.
For more information, visit the Health Catalyst Investor Relations page.
Health Catalyst (Nasdaq: HCAT) reported strong Q2 2021 financial results, exceeding revenue and Adjusted EBITDA guidance. The company achieved a positive Adjusted EBITDA of $1.7 million, marking a significant milestone since its inception. Technology revenue rose 39% to $35.5 million, while total revenue increased 38% to $59.6 million compared to Q2 2020. The recent acquisition of Twistle, effective July 1, 2021, is expected to enhance its Population Health analytics offerings. However, the company reported a net loss of $35.8 million, a 32% increase from the previous year.
Health Catalyst, a top provider of data and analytics for healthcare, announced participation in the 41st Annual Canaccord Genuity Growth Stock Conference. CFO Bryan Hunt and SVP Adam Brown will present in a fireside chat on August 11, 2021, at 2:00 p.m. ET. The company is dedicated to using data for healthcare improvements, utilizing a cloud-based platform that processes over 100 million patient records.
Health Catalyst aims for a future where all healthcare decisions are informed by data, enhancing clinical, financial, and operational outcomes.
Health Catalyst (Nasdaq: HCAT) will release its 2021 second quarter operating results on August 5, 2021, after market close. The company will host a conference call at 5 p.m. E.T. that day to discuss the results. Participants can join by calling 1-800-708-4539 (U.S.) or 1-847-619-6396 (international) using the code 50199342. A live audio webcast will be available, with a replay accessible for 90 days afterward. Health Catalyst is known for data and analytics technology that improves clinical, financial, and operational aspects for healthcare organizations.
Health Catalyst (Nasdaq: HCAT) has launched Value Optimizer, a new solution aimed at enhancing value-based care (VBC) performance for healthcare organizations. This technology addresses limitations in traditional population health tools by providing comprehensive data and insights necessary for effective VBC strategy management. Key features include a quantified view of financial opportunities, continually updated data, transparent methodologies for benchmarking, and expert guidance for maximizing performance. This solution aims to help healthcare providers lower costs while maintaining the quality of care.
Health Enterprise Partners (HEP) announced five realizations of portfolio companies and a new investment in Kno2, marking its tenth platform investment from HEP III. HEP focuses on founder-financed businesses, having previously invested in Twistle, which enhances patient engagement in healthcare. Health Catalyst (NASDAQ: HCAT) disclosed its acquisition of Twistle, enhancing its data and analytics services. Privia Health (NASDAQ: PRVA) completed a successful IPO, raising approximately $131.7 million. HEP's new investment in Kno2 will support interoperability in healthcare, aiming for better patient information exchange.
Health Catalyst (Nasdaq: HCAT) announced a definitive agreement to acquire Twistle, a patient engagement SaaS company based in Albuquerque, New Mexico. The acquisition aims to enhance patient-centered communication and improve healthcare outcomes by integrating Twistle’s workflow technology with Health Catalyst's data platform, DOS™. The transaction is expected to close in early Q3 2021 and will be funded through a mix of stock and cash. The synergy aims to drive better care and reduce costs, aligning with Health Catalyst's mission to leverage data for healthcare improvements.
Health Catalyst, a key player in data and analytics for healthcare, announced participation in the 41st Annual William Blair Growth Stock Conference on June 2, 2021, at 5:40 p.m. ET. CEO Dan Burton and SVP Adam Brown will engage in a fireside chat during the event. A webcast will be accessible via their investor relations page. Health Catalyst empowers healthcare organizations with cloud-based data platforms, utilizing insights from over 100 million patient records to enhance clinical, financial, and operational outcomes, ultimately striving for data-informed healthcare decisions.
Health Catalyst (Nasdaq: HCAT) reported a 24% increase in total revenue for Q1 2021, reaching $55.846 million compared to $45.116 million in Q1 2020. Technology revenue grew 37% to $33.839 million, while professional services revenue rose 8% to $22.007 million. Despite this growth, the company experienced a 62% increase in net loss, totaling $(28.370 million). Adjusted EBITDA improved by 86% to $(837,000). Employee satisfaction remains high, with scores in the 96th percentile. The company continues to navigate challenges from the pandemic while integrating new team members.
Health Catalyst, Inc. (Nasdaq: HCAT) will report its Q1 2021 operating results on May 6, 2021, after market close. The company also plans to host a conference call at 5 p.m. E.T. to discuss these results. Participants can access the call by dialing in or through a live audio webcast available on the company's investor relations website. The replay of the conference call will be accessible for approximately 90 days. Health Catalyst provides data and analytics technology aimed at improving healthcare outcomes.
Health Catalyst, Inc. (NASDAQ: HCAT) announced that its CEO, Dan Burton, was honored as "CEO of the Year 2021" by Utah Business. The recognition acknowledges leaders who exhibit strength and impact within their organizations. Under Burton's guidance, Health Catalyst evolved into a multibillion-dollar entity, achieving significant growth despite the pandemic. The company maintained its workforce, acquired three tech firms, and enhanced its product offerings, including nine COVID-specific capabilities. Since its IPO in July 2019, Health Catalyst has consistently ranked high in employee engagement metrics.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
What does Health Catalyst, Inc. do?
What are the main segments of Health Catalyst's business?
What recent achievements has Health Catalyst made?
What is the adaptive data architecture?
How does Health Catalyst generate its revenue?
What is the Best in KLAS ranking?
What is the significance of the MeasureAble™ ONC-Health IT certification?
How does the acquisition of Carevive Systems benefit Health Catalyst?
How does Health Catalyst support its clients?
Where can I find more information about Health Catalyst's financial performance?
